Peptides

MOTS-C: The Complete Guide

The mitochondrial-derived exercise mimetic — how it activates AMPK, improves metabolism, and why researchers call it the "exercise pill."

12 min read|Updated April 16, 2026

What is MOTS-C?

MOTS-C is a 16 amino acid mitochondrial-derived peptide encoded in the mitochondrial DNA (12S rRNA gene). Unlike most peptides which are encoded in nuclear DNA, MOTS-C originates from the mitochondria — the cell’s energy-producing organelles.

Identified in 2015 by researchers at the University of Southern California, MOTS-C has been called an “exercise mimetic” because it activates many of the same metabolic pathways as physical exercise. Natural MOTS-C levels increase roughly 12-fold during exercise, and decline significantly with age.

MOTS-C works primarily by activating AMPK, the body’s master metabolic switch. This triggers a cascade of effects including improved insulin sensitivity, enhanced fat metabolism, and increased cellular energy production.

Not FDA approved. WADA prohibited (S0 — Unapproved Substances). Available through research peptide suppliers.

How It Works

AMPK Activation

MOTS-C activates AMP-activated protein kinase (AMPK), the master energy sensor. AMPK activation shifts cells toward catabolic (energy-producing) metabolism — the same switch flipped by exercise and caloric restriction.

Folate Cycle Inhibition

Inhibits the folate cycle, redirecting cellular metabolism. This contributes to its effects on fat oxidation and glucose utilization.

Nuclear Translocation

Under metabolic stress, MOTS-C translocates from the mitochondria to the nucleus where it directly regulates gene expression — a rare and significant form of mito-nuclear communication.

Skeletal Muscle Targeting

Primarily targets skeletal muscle tissue, improving glucose uptake and fatty acid oxidation in muscle cells — mirroring the metabolic adaptations of regular exercise.

Exercise Mimetic Effects

Natural MOTS-C increases ~12-fold during exercise. Exogenous MOTS-C activates many of the same pathways, earning it the label “exercise in a peptide” — though it is not a replacement for physical activity.

Research & Benefits

MOTS-C research is still emerging, but preclinical results have been compelling enough to prompt human clinical trials (CB4211 Phase 1).

Benefit	Evidence
Insulin sensitivity	AMPK activation improves glucose uptake in skeletal muscle; key mechanism for metabolic health
Fat metabolism	Prevents diet-induced obesity in animal models; enhances fatty acid oxidation
Physical performance	Improved exercise capacity in aged mice; enhances muscle adaptation to training
Anti-aging	Endogenous levels decline with age; supplementation reverses age-related metabolic decline in animal models
Cardiovascular	Supports healthy endothelial function and vascular health via AMPK-mediated pathways
Bone health	Research suggests positive effects on bone metabolism and osteoblast activity

Key Studies

Lee et al. (2015) — Discovery paper: identified MOTS-C as a mitochondrial-derived peptide that regulates insulin sensitivity and metabolic homeostasis.
Reynolds et al. (2021) — MOTS-C levels increase ~12-fold during exercise; functions as an exercise-induced mitochondrial signal.
CB4211 (MOTS-C analog, CohBar) — Phase 1b/2a trial in NASH/obesity demonstrated target engagement and an acceptable safety profile, but did not meet primary efficacy endpoints; program discontinued in 2022. Confirmed the druggable mechanism while highlighting the challenges of translating it into human therapeutics.
Bień et al. (2025) — MOTS-c directly modulates pancreatic islet function in rats and pigs in vitro, suggesting therapeutic potential for metabolic and endocrine health.

Track MOTS-C with StackTrax

Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.

Start Tracking Free

Dosing Protocol

Standard Protocol

Dose5 mg every 5 days

Cycle20-day cycle (4 injections)

RouteSubQ

TimingMorning, fasted

By Goal

Training enhancement 200 – 500 mcg daily, or 5 mg weekly

Metabolic support 5 – 10 mg every 5 days or weekly

Longevity / wellness 5 mg every 5 days, 20-day cycle, 2 – 4× per year

Daily low-dose 200 – 500 mcg daily for 8 – 12 week cycles

Tips

Best timeMorning, fasted (mimics natural MOTS-C increase)

Pair withExercise (enhances, does not replace)

Stack withNAD+, SS-31 (mitochondrial synergy)

How to Reconstitute

MOTS-C comes as a lyophilized powder. Use bacteriostatic water and standard reconstitution technique.

Step by Step

Draw 1 mL of bacteriostatic water into a syringe
Insert needle into the vial at an angle
Let water trickle down the inside wall — do not inject directly onto the powder
Gently swirl until dissolved — do not shake
Solution should be clear and colorless; discard if cloudy

Draw Volume Reference

5 mg vial + 1 mL BAC water = 5 mg/mL

Dose	Volume	Syringe Units
200 mcg	0.04 mL	4 units
500 mcg	0.10 mL	10 units
5 mg (full dose)	1.00 mL	100 units (full syringe)

5 mg vial at 5 mg per dose = 1 dose per vial

Storage

Powder: Refrigerate 36 – 46°F; protect from light; can store frozen long-term
Reconstituted: Refrigerate; use within 7 days; do not freeze; discard if cloudy

Calculate Your Exact Dose

Use our free peptide calculator to figure out your reconstitution volume, draw amount, and syringe units.

Open Peptide Calculator

Get the Free MOTS-C Protocol Guide

Dosing cheat sheet, reconstitution reference, and cycle planning — delivered to your inbox.

Side Effects & Safety

Common

Injection site reactions (redness, mild swelling)
Fatigue or lethargy (typically transient)
Appetite changes (anecdotal reports of reduced appetite)
Sleep disturbance (if dosed late in the day)

Less Common

Headache
Mild GI discomfort

Precautions

Safety not established in: Pregnancy or breastfeeding (interestingly, MOTS-c is being investigated as a potential gestational diabetes treatment per PMID 34798268, but no human safety data exists — avoid use outside of a clinical trial)
Use caution with: Active cancer or prior malignancy, type 1 or insulin-dependent diabetes (MOTS-C improves insulin sensitivity — monitor blood glucose closely and adjust insulin/medications with your doctor), serious chronic illness, liver disease
Kidney disease: Endogenous MOTS-c levels are significantly dysregulated in end-stage kidney disease and correlate with sarcopenia risk (PMID 40005438). Exogenous dosing effects in this population are unknown — use only with close medical supervision.
Cardiopulmonary conditions: MOTS-c plasma concentrations are relevant in cardiopulmonary bypass–induced lung injury outcomes (PMID 40035775), indicating real cardiopulmonary physiological activity. Consult a physician before use if you have significant cardiac or pulmonary disease.
Glucocorticoid interaction: In vitro, MOTS-c attenuates dexamethasone-induced skeletal muscle atrophy (PMID 41732124). Users on chronic glucocorticoids (dexamethasone, prednisone) may experience altered effects — worth noting for your clinician.
Athletes: WADA prohibited — do not use if subject to anti-doping testing

FAQ

How fast does it work?

Energy and endurance improvements often noticed within the first 1 – 2 weeks. Metabolic and body composition changes develop over 4 – 8 weeks.

Can it replace exercise?

No. MOTS-C enhances the benefits of exercise and activates some of the same pathways, but it is not a substitute for physical activity. Best results come from pairing the two.

What biomarkers should I track?

Fasting glucose, HbA1c, fasting insulin, body composition, and exercise performance metrics. StackTrax can help you log and monitor these over time.

Why morning, fasted?

Natural MOTS-C levels peak with exercise and fasting. Morning fasted dosing aligns with the body’s natural rhythm and maximizes AMPK activation.

Where to Buy MOTS-C

Looking for MOTS-C? We recommend NextGen Peptides — third-party tested, fast shipping, and trusted by the StackTrax community.

NextGen Peptides

Third-party tested

Shop Now

10% off with code

Exclusive StackTrax discount

Track Your MOTS-C Protocol

Track MOTS-C with StackTrax

Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.

Start Tracking Free

Disclaimer: This guide is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. The compounds discussed are not FDA approved for human use. Always consult a qualified healthcare provider before starting any new supplement or peptide protocol. StackTrax does not sell peptides or supplements directly — purchase links go to third-party vendors. StackTrax is not responsible for the products, quality, or business practices of any third-party vendor. This page contains affiliate links — StackTrax may earn a commission on purchases at no extra cost to you.

@getstacktrax

What is MOTS-C?

Not FDA approved. WADA prohibited (S0 — Unapproved Substances). Available through research peptide suppliers.

How It Works

AMPK Activation

Folate Cycle Inhibition

Inhibits the folate cycle, redirecting cellular metabolism. This contributes to its effects on fat oxidation and glucose utilization.

Nuclear Translocation

Under metabolic stress, MOTS-C translocates from the mitochondria to the nucleus where it directly regulates gene expression — a rare and significant form of mito-nuclear communication.

Skeletal Muscle Targeting

Primarily targets skeletal muscle tissue, improving glucose uptake and fatty acid oxidation in muscle cells — mirroring the metabolic adaptations of regular exercise.

Exercise Mimetic Effects

Research & Benefits

MOTS-C research is still emerging, but preclinical results have been compelling enough to prompt human clinical trials (CB4211 Phase 1).

Benefit	Evidence
Insulin sensitivity	AMPK activation improves glucose uptake in skeletal muscle; key mechanism for metabolic health
Fat metabolism	Prevents diet-induced obesity in animal models; enhances fatty acid oxidation
Physical performance	Improved exercise capacity in aged mice; enhances muscle adaptation to training
Anti-aging	Endogenous levels decline with age; supplementation reverses age-related metabolic decline in animal models
Cardiovascular	Supports healthy endothelial function and vascular health via AMPK-mediated pathways
Bone health	Research suggests positive effects on bone metabolism and osteoblast activity

Key Studies

Lee et al. (2015) — Discovery paper: identified MOTS-C as a mitochondrial-derived peptide that regulates insulin sensitivity and metabolic homeostasis.
Reynolds et al. (2021) — MOTS-C levels increase ~12-fold during exercise; functions as an exercise-induced mitochondrial signal.
CB4211 (MOTS-C analog, CohBar) — Phase 1b/2a trial in NASH/obesity demonstrated target engagement and an acceptable safety profile, but did not meet primary efficacy endpoints; program discontinued in 2022. Confirmed the druggable mechanism while highlighting the challenges of translating it into human therapeutics.
Bień et al. (2025) — MOTS-c directly modulates pancreatic islet function in rats and pigs in vitro, suggesting therapeutic potential for metabolic and endocrine health.

Dosing Protocol

Standard Protocol

Dose5 mg every 5 days

Cycle20-day cycle (4 injections)

RouteSubQ

TimingMorning, fasted

By Goal

Training enhancement 200 – 500 mcg daily, or 5 mg weekly

Metabolic support 5 – 10 mg every 5 days or weekly

Longevity / wellness 5 mg every 5 days, 20-day cycle, 2 – 4× per year

Daily low-dose 200 – 500 mcg daily for 8 – 12 week cycles

Tips

Best timeMorning, fasted (mimics natural MOTS-C increase)

Pair withExercise (enhances, does not replace)

Stack withNAD+, SS-31 (mitochondrial synergy)

How to Reconstitute

MOTS-C comes as a lyophilized powder. Use bacteriostatic water and standard reconstitution technique.

Step by Step

Draw 1 mL of bacteriostatic water into a syringe
Insert needle into the vial at an angle
Let water trickle down the inside wall — do not inject directly onto the powder
Gently swirl until dissolved — do not shake
Solution should be clear and colorless; discard if cloudy

Draw Volume Reference

5 mg vial + 1 mL BAC water = 5 mg/mL

Dose	Volume	Syringe Units
200 mcg	0.04 mL	4 units
500 mcg	0.10 mL	10 units
5 mg (full dose)	1.00 mL	100 units (full syringe)

5 mg vial at 5 mg per dose = 1 dose per vial

Storage

Powder: Refrigerate 36 – 46°F; protect from light; can store frozen long-term
Reconstituted: Refrigerate; use within 7 days; do not freeze; discard if cloudy

Side Effects & Safety

Common

Injection site reactions (redness, mild swelling)
Fatigue or lethargy (typically transient)
Appetite changes (anecdotal reports of reduced appetite)
Sleep disturbance (if dosed late in the day)

Less Common

Headache
Mild GI discomfort

Precautions

Safety not established in: Pregnancy or breastfeeding (interestingly, MOTS-c is being investigated as a potential gestational diabetes treatment per PMID 34798268, but no human safety data exists — avoid use outside of a clinical trial)
Use caution with: Active cancer or prior malignancy, type 1 or insulin-dependent diabetes (MOTS-C improves insulin sensitivity — monitor blood glucose closely and adjust insulin/medications with your doctor), serious chronic illness, liver disease
Kidney disease: Endogenous MOTS-c levels are significantly dysregulated in end-stage kidney disease and correlate with sarcopenia risk (PMID 40005438). Exogenous dosing effects in this population are unknown — use only with close medical supervision.
Cardiopulmonary conditions: MOTS-c plasma concentrations are relevant in cardiopulmonary bypass–induced lung injury outcomes (PMID 40035775), indicating real cardiopulmonary physiological activity. Consult a physician before use if you have significant cardiac or pulmonary disease.
Glucocorticoid interaction: In vitro, MOTS-c attenuates dexamethasone-induced skeletal muscle atrophy (PMID 41732124). Users on chronic glucocorticoids (dexamethasone, prednisone) may experience altered effects — worth noting for your clinician.
Athletes: WADA prohibited — do not use if subject to anti-doping testing

FAQ

How fast does it work?

Energy and endurance improvements often noticed within the first 1 – 2 weeks. Metabolic and body composition changes develop over 4 – 8 weeks.

Can it replace exercise?

No. MOTS-C enhances the benefits of exercise and activates some of the same pathways, but it is not a substitute for physical activity. Best results come from pairing the two.

What biomarkers should I track?

Fasting glucose, HbA1c, fasting insulin, body composition, and exercise performance metrics. StackTrax can help you log and monitor these over time.

Why morning, fasted?

Natural MOTS-C levels peak with exercise and fasting. Morning fasted dosing aligns with the body’s natural rhythm and maximizes AMPK activation.